Scientists probe why Last-Resort schizophrenia drug works better
NCT ID NCT05741502
Summary
This study aimed to understand why the antipsychotic drug clozapine is more effective for people with schizophrenia who don't respond to other treatments. Researchers compared blood levels of inflammation markers in a small group of patients taking clozapine versus those taking other antipsychotics. The goal was to see if reduced inflammation explains clozapine's unique benefits for severe symptoms and suicidal thoughts.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT-RESISTANT SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ohio State University Harding Hospital
Columbus, Ohio, 43210, United States
Conditions
Explore the condition pages connected to this study.